Zoekresultaten - 145 results
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022
hospital study team Source: Eurosurveillance, Volume 28, Issue 47 (2023) Keywords: COVID-19 Omicron Vaccine effectiveness Service: Maladies virales Virale ziekten Viral diseases Épidémiologie des maladies ...
Mycoplasma pneumoniae: delayed re-emergence after COVID-19 pandemic restrictions.
Publication Type: Peer reviewed scientific article Authors: Meyer Sauteur, Patrick M; Beeton, Michael L; European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Mycoplasma and Chlamydia Infections (ESGMAC), and the ESGMA ...
Factors underlying COVID-19 booster vaccine uptake among adults in Belgium
Source: BMC Res Notes, Volume 16, Issue 1 (2023) Keywords: Adult Aged Belgium Biological Transport COVID-19 COVID-19 Vaccines Female Humans Immunization Programs Male Vaccination Abstract: OBJECTIVE: This ...
Monitoring COVID-19 vaccine effectiveness against COVID-19 hospitalisation and death using electronic health registries in ≥65 years old population in six European countries, October 2021 to November 2022.
Anthony; Nicolay, Nathalie; Monge, Susana; VEBIS-Lot4 working group Source: Influenza Other Respir Viruses, Volume 17, Issue 11 (2023) Keywords: Aged COVID-19 COVID-19 Vaccines Electronics Hospitalization ...
Seasonal and inter-seasonal RSV activity in the European Region during the COVID-19 pandemic from autumn 2020 to summer 2022.
Keywords: COVID-19 Humans Pandemics Population Surveillance Respiratory Syncytial Virus Infections Respiratory Syncytial Virus, Human SARS-CoV-2 Seasons Abstract: BACKGROUND: The emergence of the Severe Acute ...
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022.
Vaccines Europe Hospitalization Humans Pneumonia RNA, Messenger SARS-CoV-2 Vaccine Efficacy Abstract: IntroductionThe I- MOVE- COVID-19 and VEBIS hospital networks have been measuring COVID-19 vaccine ...
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021.
study teams (in addition to the named authors) Source: Euro Surveill, Volume 28, Issue 47 (2023) Keywords: Adult BNT162 Vaccine COVID-19 Europe Hospitalization Humans RNA, Viral SARS-CoV-2 Vaccine ...
Federated causal inference based on real-world observational data sources: application to a SARS-CoV-2 vaccine effectiveness assessment.
Causality COVID-19 COVID-19 Vaccines Humans SARS-CoV-2 Vaccine Efficacy Abstract: INTRODUCTION: Causal inference helps researchers and policy-makers to evaluate public health interventions. When comparing ...
Surveillance épidémiologique de la rougeole (Morbillivirus)- 2022
de symptômes. La forte baisse du nombre de cas qui avait débuté en 2020 se maintient donc, même après la fin de la pandémie du COVID-19. En 2019, 480 cas avaient encore été enregistrés, pour passer ...
Factors influencing SARS-CoV-2 infection rate in Belgian nursing homes’ residents during the first wave of COVID-19 pandemic
(2022) Keywords: COVID-19 long-term care facilities Abstract: In April 2020, Belgium experienced high numbers of fatal COVID-19 cases among nursing home (NH) residents. In response, a mass testing campaign ...